Use + Harm Reduction
EU to Fund Study of Psilocybin for Patients in Palliative Care
The European Union is putting money into a psychedelic study with patients who are ...
Australia Tightens the Screw Even More Against Vaping
One million additional GP appointments will be needed in Australia annually, according to the ...
UK Makes Cytisine Available as Prescription Smoking-Cessation Drug
For people in the United Kingdom who wish to quit smoking, a new oral ...
Mathematical Model Illuminates Potential of Safe Consumption Sites
New research aims to put numbers on how safe consumption sites (also known as ...
Stimulant Treatment Research Finally Uses Outcome Besides Abstinence
To whatever degree harm reduction has gotten mainstreamed, it still hasn’t budged the meaning ...
UK Medical Cannabis Access Beset With Social and Systemic Barriers
While a number of countries have been taking recent steps toward legalizing cannabis, the ...
Naltrexone as Opioid Treatment: Who Does It Work For, Besides Cops?
Of the three Food and Drug Administration-approved medications for opioid use disorder (MOUD), two ...
How Common Is Fentanyl in Samples of Cocaine and Meth?
At face value, a recent study shows that fentanyl was quite common in samples ...
Smoking Cessation, Weight Gain and Vapes
The benefits of smoking cessation are numerous and indisputable. But one of the few ...
Neither Snake Oil Nor Silver Bullet: Ibogaine for Opioid Use Disorder
“But as fascinating as the pharmacology of ibogaine [is], it is the chemistry of ...
